The EMA has given the green light to anti-Covid vaccines adapted to

Photo by Alexandra_Koch on Pixabay

Reading time:< 1 minute

The European Medicines Agency (EMA) approved, on Thursday, vaccines adapted to the Omicron variant from Pfizer/BioNTech and Moderna.

“The sera target the Omicron BA.1 sub-variant in addition to the original strain,” the EMA said, according to AFP, as quoted by SpotMedia.

Moderna will supply the European Union with 70 million doses of the vaccine in the first two months, with 8 to 11 million expected to be available as early as the first week of September.

Germany is scheduled to receive 4 million doses in the first two weeks and has already announced that the vaccination campaign will start next week.

Health Minister Karl Lauterbach said the approval of the BA.1 vaccine represents a qualitative leap in the fight against the pandemic, as vaccines are now available that work well against all previously known variants of the virus, Reuters reports.

“From next week, vaccinations can start with the new doses. Now is the optimal time to close the vaccination loopholes for the fall,” he said.